KLF9 and prostate carcinoma: Targeting by miR-141-3p of the 3′ UTR of KLF9 mRNA may underlie tumor-mediated loss of KLF9 expression since this miRNA is induced in prostate tumors, and moreover, enhances sphere formation by prostate cancer cells in vitro [229].